Carbon Monoxide Hyperbaric Oxygen With Steroid Therapy

Trial statusNot yet recruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age19+
SponsorUniversity of Nebraska

About this trial

Hyperbaric Oxygen Therapy (HBO) is routine treatment of carbon monoxide (CO) poisoning to prevent delayed neurological sequelae. This study looking to see if neurologic outcomes are improved with the addition of dexamethasone. CO poisoning can initiate a free radical mediated process that can instigate a demyelinating process resulting in long term neurological sequelae in some, but not all patients. In other demyelinating disorders, steroids are a part of first line treatment. HBO is already used for acute CO poisoning, so this pilot study will try to ascertain if the addition of steroids in concert with each hyperbaric oxygen session will yield improved outcomes.

Eligibility criteria

Qualifiers

Acute CO poisoning, intentional or non-intentional exposure, receiving HBO treatment during hospitalization

Age >18 years

Nebraska Medicine admission

Disqualifiers

Mechanical ventilation

No hospital admission or admission to hospital Critical Care Medicine Service

Allergy to dexamethasone

Pre-Existing neurological condition confounding outcome determination

Trial design

Treatments tested in this trial

  • saline placebo
  • Dexamethasone

Treatment groups

20 Participants
are divided into 2 treatment groups

Sponsors and collaborators